Cargando…
Auranofin Rapidly Eradicates Methicillin-resistant Staphylococcus aureus (MRSA) in an Infected Pressure Ulcer Mouse Model
Pressure ulcers (PUs) frequently occur in individuals with limited mobility including patients that are hospitalized or obese. PUs are challenging to resolve when infected by antibiotic-resistant bacteria, particularly methicillin-resistant Staphylococcus aureus (MRSA). In this study, we investigate...
Autores principales: | Mohammad, Haroon, Abutaleb, Nader S., Seleem, Mohamed N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190694/ https://www.ncbi.nlm.nih.gov/pubmed/32350417 http://dx.doi.org/10.1038/s41598-020-64352-2 |
Ejemplares similares
-
Evaluation of ebselen in resolving a methicillin-resistant Staphylococcus aureus infection of pressure ulcers in obese and diabetic mice
por: Mohammad, Haroon, et al.
Publicado: (2021) -
Investigating auranofin for the treatment of infected diabetic pressure ulcers in mice and dermal toxicity in pigs
por: Mohammad, Haroon, et al.
Publicado: (2021) -
Antibacterial Evaluation of Synthetic Thiazole Compounds In Vitro and In Vivo in a Methicillin-Resistant Staphylococcus aureus (MRSA) Skin Infection Mouse Model
por: Mohammad, Haroon, et al.
Publicado: (2015) -
In vivo efficacy of auranofin in a hamster model of Clostridioides difficile infection
por: Abutaleb, Nader S., et al.
Publicado: (2021) -
Auranofin, at clinically achievable dose, protects mice and prevents recurrence from Clostridioides difficile infection
por: Abutaleb, Nader S., et al.
Publicado: (2020)